TRIM7-AS1

Across TCGA pan-cancer cohorts, TRIM7-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated TRIM7-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher TRIM7-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRIM7-AS1 expression acts as an unfavorable survival marker, although some lineages such as DLBC and MESO show a favorable association.

ACC, KIRP, and DLBC are the cancer types where TRIM7-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.170	0.697	<.001	47	view →
KIRP	OS	Median	All	0.583	0.792	.016	20	view →
DLBC	DFS	Median	III,IV	0.873	0.371	.019	19	view →
MESO	DFS	Median	All	0.596	0.295	.024	12	view →
READ	DFS	Tertile	III,IV	0.603	0.870	.017	10	view →
ESCA	DFS	Tertile	All	0.399	0.605	.009	10	view →
STAD	OS	Median	IV	0.514	0.228	.004	9	view →
OV	OS	Quartile	All	0.916	0.800	.004	6	view →
KICH	DFS	Median	All	0.809	0.971	.021	4	view →
UVM	OS	Median	All	0.528	0.778	.024	4	view →
LUSC	OS	Median	II,III,IV	0.778	0.681	.038	4	view →
BLCA	OS	Quartile	IV	0.300	0.769	.004	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

TRIM7-AS1–ACC (DFS)

Open the ACC breakdown →